BayMark Announces Acquisition Of Opioid Treatment Program In Washington, D.C. Share Article BayMark Health Services acquisition of the well-known PIDARC medication-assisted treatment program for opioid use is its first in Washington, D.C. Now, more than ever, access to evidence-based care is critical, and BayMark looks to partner with providers who have an established commitment to patient care and clinical excellence; PIDARC has absolutely established that in Washington, D.C. LEWISVILLE, Texas (PRWEB) March 16, 2021 BayMark Health Services recently completed the acquisition of PIDARC (Partners in Drug Abuse Rehabilitation Counseling), a prominent medication-assisted treatment (MAT) in Washington, D.C. The program provides treatment for opioid use disorder (OUD) offering high-quality, effective medication-assisted treatment (MAT) services with methadone supported by substance use counseling and linkages to a variety of community resources. The staff of PIDARC will continue their excellent work under BayMark’s experienced leadership team.